BioAtla (BCAB) Invested Capital (2020 - 2025)
BioAtla's Invested Capital history spans 6 years, with the latest figure at -$36.2 million for Q4 2025.
- For Q4 2025, Invested Capital fell 353.69% year-over-year to -$36.2 million; the TTM value through Dec 2025 reached -$36.2 million, down 353.69%, while the annual FY2025 figure was -$36.2 million, 353.69% down from the prior year.
- Invested Capital reached -$36.2 million in Q4 2025 per BCAB's latest filing, down from -$31.2 million in the prior quarter.
- In the past five years, Invested Capital ranged from a high of $230.7 million in Q3 2021 to a low of -$36.2 million in Q4 2025.
- Average Invested Capital over 5 years is $98.7 million, with a median of $109.6 million recorded in 2023.
- Peak YoY movement for Invested Capital: surged 440.04% in 2021, then plummeted 353.69% in 2025.
- A 5-year view of Invested Capital shows it stood at $210.8 million in 2021, then fell by 14.46% to $180.3 million in 2022, then tumbled by 60.81% to $70.7 million in 2023, then crashed by 79.82% to $14.3 million in 2024, then tumbled by 353.69% to -$36.2 million in 2025.
- Per Business Quant, the three most recent readings for BCAB's Invested Capital are -$36.2 million (Q4 2025), -$31.2 million (Q3 2025), and -$16.7 million (Q2 2025).